Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04754022

Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery

An International, Multi-centre, Randomized Controlled Trial to Assess Transfusion Thresholds in Younger Patients Undergoing Cardiac Surgery

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
1,440 (estimated)
Sponsor
Unity Health Toronto · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

TRICS-IV is an international, multi-centre, open-label randomized controlled trial of two commonly used transfusion strategies in moderate to high risk patients who are 65 years of age or younger undergoing cardiac surgery on cardiopulmonary bypass, using a superiority trial design.

Conditions

Interventions

TypeNameDescription
OTHERRestrictive Transfusion StrategyPatients will receive a RBC transfusion if their Hb concentration is \<75 g/L (\<7.5 g/dL; \<4.7mmol/L) intraoperatively and/or postoperatively.
OTHERLiberal transfusion strategyPatients will receive a RBC transfusion if their Hb concentration is \<95 g/L (\<9.5 g/dL; \<5.9mmol/L) intraoperatively, or postoperatively in the ICU; and/or \<85 g/L (\< 8.5 g/dL; \<5.3mmol/L) on the ward.

Timeline

Start date
2021-11-01
Primary completion
2025-12-01
Completion
2026-06-01
First posted
2021-02-15
Last updated
2024-11-21

Locations

54 sites across 16 countries: United States, Australia, Canada, Colombia, Egypt, Greece, India, Namibia, Nepal, Romania, Russia, Singapore, South Africa, Spain, Switzerland, United Kingdom

Source: ClinicalTrials.gov record NCT04754022. Inclusion in this directory is not an endorsement.

Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery (NCT04754022) · Clinical Trials Directory